Retinal nerve fiber layer in beta-thalassemia major: a comparative study
https://doi.org/10.21516/2072-0076-2025-18-2-102-107
Abstract
Beta-thalassemia is a hereditary blood disorder which occurs due to defective beta-globin gene synthesis. It is characterized by blood deficiency caused by ineffective erythropoiesis, hemolysis, and iron overload due to repeated transfusions. The purpose of the is study to find out the changes in retinal nerve fiber layer (RNFL) thickness as a result of Beta-thalassemia major and to compare the values with healthy individuals. Material and methods. This cross-sectional study was performed on a total of 56 beta-thalassemia major cases and 64 healthy controls from December 2023 to June 2024. The mean age of the cases (18.42 ± 4.05 years) and controls (17.45 ± 4.02 years) was significantly similar (p = 0.190). All the subjects undergone standard ophthalmological examination followed by RNFL thickness measurement using Heidelberg Spectralis OCT (Optical Coherence Tomography). Results. The RNFL thickness showed significant difference between the case and control groups. The p-value for global, inferior, nasal, and temporal RNFL thickness was < 0.001, while for superior RNFL p-value was 0.006. A significant correlation of global, inferior, and nasal RNFL measurements was found with the duration of thalassemia (p = 0.01, p = 0.01, p < 0.001), however, the global and nasal RNFL were found to be thinner in the cases receiving iron chelation monotherapy (p = 0.048, p = 0.006). Conclusion. The study concludes that the RNFL was significantly thinner in beta-thalassemia major cases in comparison to healthy controls. Moreover, only global, inferior, and nasal RNFL revealed to have a significant correlation with the thalassemia duration and iron chelation therapy.
About the Authors
M. Firdous
Lincoln University College
Malaysia
Malaysia
Maryam Firdous — senior lecturer, department of health sciences.
Wisma Lincoln, No. 12–18, Jalan SS 6/12, 47301, Petaling Jaya, Selangor Darul Ehsan
M. F. Umer
College of Dentistry, King Faisal University
Saudi Arabia
Saudi Arabia
Muhammad Farooq Umer — assistant professor, department of preventive dental sciences.
31982, Hofuf, Al-Ahsa
S. P. Chandran
Lincoln University College
Malaysia
Malaysia
Suriyakala Perumal Chandran — head of the department, faculty of medicines.
Wisma Lincoln, No. 12–18, Jalan SS 6/12, 47301, Petaling Jaya, Selangor Darul Ehsan
References
1. Ozdem r S, Oruc MA, Yaz c oglu B, Turkan S. Premarital hemoglobinopathy screening program results of a province in the Black Sea region of Turkey: three years’ experience. Postgrad Med. 2023 Nov 17; 135 (8): 818–23. doi: 10.1080/00325481.2023.2285726
2. Baig R, Zahid N, Kausar F, et al. Burden of ocular abnormalities in patients with beta thalassaemia: a cross-sectional study. BMJ Open Ophthalmol. 2023 Jul 1; 8 (1): e001293. doi: 10.1136/bmjophth-2023-001293
3. Aksoy A, Aslan L, Aslankurt M, et al. Retinal fiber layer thickness in children with thalessemia major and iron deficiency anemia. Semin Ophthalmol. 2014 Jan; 29 (1): 22–6. doi: 10.3109/08820538.2013.839811
4. Ali S, Mumtaz S, Shakir HA, et al. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021 Dec; 9 (12): e1788. doi: 10.1002/mgg3.1788
5. Betts M, Flight PA, Paramore LC, et al. Systematic literature review of the burden of disease and treatment for transfusion-dependent -Thalassemia. Clin Ther. 2020 Feb; 42 (2): 322-37.e2. doi: 10.1016/j.clinthera.2019.12.003
6. El-Beshlawy A, Dewedar H, Hindawi S, et al. Management of transfusion-dependent -thalassemia (TDT): Expert insights and practical overview from the Middle East. Blood Rev. 2024 Jan 1; 63: 101138. doi: 10.1016/j.blre.2023.101138
7. Nuzzi R, Geronazzo G, Tridico F, et al. Long-term effects of iron chelating agents on ocular function in patients with thalassemia major. Clin Ophthalmol. 2021 May 20; 15: 2099–109. doi: 10.2147/OPTH.S300974
8. Uzun F, Karaca EE, Y ld z Yerlikaya G, F nd k H, Ak n M. Retinal nerve fiber layer thickness in children with -thalassemia major. Saudi J Ophthalmol. 2017 Oct-Dec; 31 (4): 224–8. doi: 10.1016/j.sjopt.2017.10.001
9. Heydarian S, Jafari R, Dailami KN, et al. Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies. Int Ophthalmol. 2020 Feb 1; 40 (2): 511–27. doi: 10.1007/s10792-019-01189-3
10. Haghpanah S, Zekavat OR, Safaei S, et al. Optical coherence tomography findings in patients with transfusion-dependent -thalassemia. BMC Ophthalmol. 2022 Jun 24; 22: 279. https://doi.org/10.1186/s12886-022-02490-z
11. Akritidou F, Praidou A, Papamitsou T, Kozobolis V, Labiris G. Ocular manifestations in patients with transfusion-dependent -thalassemia. Hippokratia. 2021; 25 (2): 79–82. PMID: 35937508.
12. Koctekin B, Dogan B, Erdem R, et al. Investigation of the color discrimination ability using the Farnsworth-Munsell 100-hue test and structural changes by SS-OCT in patients with transfusion-dependent beta-thalassemia. Photodiagnosis Photodyn Ther. 2023 Sep; 43(bay): 103716. doi: 10.1016/j.pdpdt.2023.103716
13. Bayramoglu SE, Aydogan G, Erdogan M, Ekinci DY, Sayin N. Evaluation of optical coherence tomography findings and choroidal thickness in beta-thalassemia major patients using chelation therapy. Beyoglu Eye J. 2022; 7 (4): 267–72. doi: 10.14744/bej.2022.62534
14. Tsapardoni F, Makri OE, Lazaris V, et al. Choroidal thickness evaluation in a transfusion-dependent beta-thalassemia Greek population. Clin Ophthalmol Auckl NZ. 2020 Dec 24; 14: 4511–8.
15. El Sehmawy AAEWI, El-Haddad N. The cup/disc ratio, retinal nerve layer, and macular thickness in children with B-thalassemia major. Sci J Al-Azhar Med Fac Girls. 2019 Apr; 3 (1): 117. doi: 10.2147/OPTH.S285312
16. Ulusoy MO, T rk H, K van SA. Spectral domain optical coherence tomography findings in Turkish sickle-cell disease and beta thalassemia major patients. J Curr Ophthalmol. 2019 Sep; 31 (3): 275–80. doi: 10.1016/j.joco.2019.01.012
17. Basiony AI, Elsharkawy NFR, El-Hawy MA, Zaky AG. Retinal nerve fiber layer thickness in children with -thalassemia major. Delta J Ophthalmol. 2022 Mar; 23 (1): 37. doi:10.4103/djo.djo_51_21
18. Shin JW, Sung KR, Song MK. Ganglion cell-inner plexiform layer and retinal nerve fiber layer changes in glaucoma suspects enable prediction of glaucoma development. Am J Ophthalmol. 2020 Feb 1; 210: 26–34. doi: 10.1016/j.ajo.2019.11.002
19. Sato A, Fukui E, Ohta K. Retinal thickness of myopic eyes determined by spectralis optical coherence tomography. Br J Ophthalmol. 2010 Dec 1; 94 (12): 1624–8. doi: 10.1136/bjo.2009.165472
20. Mrugacz M, Bakunowicz-Lazarczyk A. Optical coherence tomography measurement of the retinal nerve fiber layer in normal and juvenile glaucomatous eyes. Ophthalmologica. 2005 Mar 24; 219 (2):80–5. doi: 10.1159/000083265
21. Jnawali A, Mirhajianmoghadam H, Musial G, Porter J, Ostrin LA. The optic nerve head, lamina cribrosa, and nerve fiber layer in non-myopic and myopic children. Exp Eye Res. 2020 Jun 1; 195: 108041. doi: 10.1016/j.exer.2020.108041
22. Kirbas S, Turkyilmaz K, Tufekci A, Durmus M. Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol. 2013 Mar; 33 (1): 62–5. doi: 10.1097/WNO.0b013e3182701745
23. Stefanutti C, Mesce D, Pacella F, et al. Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis. Atheroscler Suppl. 2019 Dec 1; 40: 49–54. doi: 10.1016/j.atherosclerosissup.2019.08.031
24. Acer S, Balc YI, Pekel G, et al. Retinal nerve fiber layer thickness and retinal vessel calibers in children with thalassemia minor. SAGE Open Med. 2016 Jan 1; 4: 2050312116661683. doi: 10.1177/2050312116661683
Review
For citations:
Firdous M., Umer M.F., Chandran S.P. Retinal nerve fiber layer in beta-thalassemia major: a comparative study. Russian Ophthalmological Journal. 2025;18(2):102-107. https://doi.org/10.21516/2072-0076-2025-18-2-102-107
Views:
102
Email this article 